Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion October 8, 2023 by EditorBristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
